Today is Friday, June 11, and here are five things to know in Montgomery County. 1.Economic Recovery Town Hall: Montgomery County’s COVID-19 Economic Revitalization and Recovery program continues its series of… Read More
Gov. Larry Hogan and other leaders visited Gaithersburg on Thursday to tour the site of Novavax’s future global headquarters. More than a year ago, Novavax began developing a promising COVID-19 vaccine. Stan… Read More
Today is Thursday, June 10, and here are five things to know in Montgomery County. 1. Gov. Hogan Visits Novavax in Montgomery County: Novavax, a biotechnology company developing next-generation vaccines for… Read More
Gov. Larry Hogan is heading to Gaithersburg on Thursday to tour the site of Novavax’s future 180,000 square foot Vaccine Innovation Campus and Global Headquarters. This comes after the Gaithersburg… Read More
Vaccine development company Novavax, headquartered in Gaithersburg, announced Monday that it expanded Phase 3 clinical trials for its COVID-19 vaccine candidate to include adolescents. The trials will include up to… Read More
Novavax confirmed high levels of vaccine efficacy against both original and variant COVID-19 strains in recent United Kingdom and South Africa trials. In a press release Thursday, the Gaithersburg-based drug… Read More
Altimmune, Inc. announced Wednesday that it was approved by the FDA to begin Phase 1 clinical trials for AdCOVID, its single-dose nasal spray COVID-19 vaccine candidate. The clinical stage biopharmaceutical… Read More
Novavax, a vaccine development company headquartered in Gaithersburg, announced Thursday that it entered into a Memorandum of Understanding (MOU) with an international vaccine organization to provide more than 1 billion… Read More
Novavax, a vaccine development company headquartered in Gaithersburg, says its COVID-19 vaccine candidate showed 89.3% efficacy in UK clinical trials. The UK study enrolled more than 15,000 volunteers, according to… Read More
Novavax, una empresa de desarrollo de vacunas con sede en Gaithersburg, ha iniciado la Fase 3 para su candidata a vacuna COVID-19. Es el quinto candidato en alcanzar la Fase… Read More
Novavax, a vaccine development company headquartered in Gaithersburg, has initiated Phase 3 for its COVID-19 vaccine candidate. It is the fifth candidate to reach Phase 3 in the U.S., after… Read More
Novavax, que tiene su sede en Gaithersburg e instalaciones en Rockville, anunció que ha pasado a la Fase 3 de su ensayo de eficacia para su vacuna COVID-19. Prevent-19 está… Read More